We, as a society, have made tremendous investments in developing the scientific infrastructure to enable breakthrough discoveries on the primary biological risk factors for common disorders, such as diabetes, asthma, and cardiovascular disease (and related quantitative traits), that account for a disproportionate and growing share of public health care expenditures. While it is clear that the relationships between genetic variation and common disease phenotypes are complex, there is good preliminary evidence that identifying genetic risk factors for common disorders will improve understanding of their etiology and pathogenesis, leading to more specific and effective therapies. Moreover, since virtually all common disease arises as a consequence of the actions and interactions of both genetic and non-genetic risk factors, the identification of genetic risk factors should allow design of epidemiological studies to identify more specific non-genetic risk factors that might be cost-effective targets for prevention of disease. The recent development of high throughput platforms for very large-scale SNP genotyping makes genome-wide association mapping a viable additional tool in the effort to identify genetic risk factors for common disease. Effective use of this tool, however, will require considerable methodological development. Thus, we propose to develop (including software tools and web interfaces) and apply a variety of approaches for facilitating genome-wide association studies, including 1) improved allele/genotype calling algorithms for high-throughput genotyping platforms (to reduce non-random patterns of missing data), and 2) measures of information content for linkage disequilibrium mapping, analogous to those previously developed for linkage mapping. We will utilize these tools, as well as novel analytic approaches that we are developing, to conduct genome-wide association mapping studies on 3) more than 100,000 SNPs typed genome-wide in 350 Mexican Americans with type 2 diabetes and a random sample of 350 Mexican Americans from Starr County, TX; and 4) more than 500,000 SNPs typed in 700 Hutterites with data on a variety of phenotypes related to metabolic, pulmonary and cardiovascular disease. Our proposal builds on long-standing collaborations in methods development and data analysis among members of our research team, which includes human, population, and statistical geneticists and statisticians. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL084715-03
Application #
7420985
Study Section
Special Emphasis Panel (ZHG1-HGR-P (J1))
Program Officer
Gan, Weiniu
Project Start
2006-06-15
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2011-05-31
Support Year
3
Fiscal Year
2008
Total Cost
$279,630
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Zhang, Wei; Gamazon, Eric R; Zhang, Xu et al. (2015) SCAN database: facilitating integrative analyses of cytosine modification and expression QTL. Database (Oxford) 2015:
Gamazon, E R; Badner, J A; Cheng, L et al. (2013) Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry 18:340-6
Gamazon, Eric R; Huang, R Stephanie; Cox, Nancy J (2013) SCAN: a systems biology approach to pharmacogenomic discovery. Methods Mol Biol 1015:213-24
Elbein, Steven C; Gamazon, Eric R; Das, Swapan K et al. (2012) Genetic risk factors for type 2 diabetes: a trans-regulatory genetic architecture? Am J Hum Genet 91:466-77
Reimherr, Matthew; Nicolae, Dan L (2011) You've gotta be lucky: Coverage and the elusive gene-gene interaction. Ann Hum Genet 75:105-11
Below, J E; Gamazon, E R; Morrison, J V et al. (2011) Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals. Diabetologia 54:2047-55
Parra, E J; Below, J E; Krithika, S et al. (2011) Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas. Diabetologia 54:2038-46
Gamazon, Eric R; Nicolae, Dan L; Cox, Nancy J (2011) A study of CNVs as trait-associated polymorphisms and as expression quantitative trait loci. PLoS Genet 7:e1001292
Gamazon, Eric R; Huang, R Stephanie; Dolan, M Eileen et al. (2011) Copy number polymorphisms and anticancer pharmacogenomics. Genome Biol 12:R46
Pluzhnikov, Anna; Below, Jennifer E; Konkashbaev, Anuar et al. (2010) Spoiling the whole bunch: quality control aimed at preserving the integrity of high-throughput genotyping. Am J Hum Genet 87:123-8

Showing the most recent 10 out of 21 publications